Synapse - Dmitriy Zamarin

Results (53)

Molecular and tumor microenvironmental characterization of HPV-negative invasive squamous cell carcinoma of the vulva

Meeting Abstract

Moufarrij, S.; Filippova, O.; Paula, A. D.; Heredia, J. B.; Leitao, M.; O'Cearbhaill, R.; Abu-Rustum, N.; Park, K.; Weigelt, B.; Zamarin, D.
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: A case series

Journal Article

Sia, T. Y.; Wan, V.; Finlan, M.; Zhou, Q. C.; Iasonos, A.; Zivanovic, O.; Sonoda, Y.; Chi, D. S.; Long Roche, K.; Jewell, E.; more...
International Journal of Gynecological Cancer (2024)

Fulltext@MSK | Save

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

Journal Article

Kahn, R. M.; Selenica, P.; Boerner, T.; Roche, K. L.; Xiao, Y.; Sia, T. Y.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Evolution of peripheral and tumor immune parameters as biomarkers of differential sequencing of immune checkpoint blockade and chemoradiotherapy in locally advanced cervical cancer: An NRG Oncology/GOG Study

Meeting Abstract

Zamarin, D.; Deng, W.; Lankes, H.; Ghamande, S.; Holman, L.; Mathews, C.; Park, K.; Banbury, B.; Sherry, N.; Kim, H.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets

Journal Article

Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival

Meeting Abstract

Kahn, R. M.; Selenica, P.; Boerner, T.; Xiao, Y.; Sia, T.; Sheehan, M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; O'Cearbhaill, R. E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG Oncology/Gynecologic Oncology Group study 0283

Journal Article

O'Cearbhaill, R. E.; Miller, A.; Soslow, R. A.; Lankes, H. A.; DeLair, D.; Segura, S.; Chavan, S.; Zamarin, D.; DeBernardo, R.; Moore, K.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Phase I study of a multivalent WT1 peptide vaccine (galinpepimut-S) in combination with nivolumab in patients with WT1-expressing ovarian cancer in second or third remission

Journal Article

Manning-Geist, B. L.; Gnjatic, S.; Aghajanian, C.; Konner, J.; Kim, S. H.; Sarasohn, D.; Soldan, K.; Tew, W. P.; Sarlis, N. J.; Zamarin, D.; more...
Cancers (2023)

Fulltext@MSK | Save

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Journal Article

Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Germline SMARCA4 deletion as a driver of uterine cancer: An atypical presentation

Journal Article

Navitski, A.; Al-Rawi, D. H.; Makker, V.; Weigelt, B.; Zamarin, D.; Liu, Y.; Arnold, A. G.; Chui, M. H.; Mandelker, D. L.; Walsh, M.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save